JGene Biotechnology is a biotechnology company engaged in the research of gene and cell therapies for tumor treatment.
JGene Biotechnology is a research and development biotechnology company dedicated to the research and development of universal CAR-NK/T products from iPS. It is hoped that the large-scale production of CAR-NK/T from iPS will provide cancer patients with spot-type, price-friendly, and affordable new immune cell therapy products. Recently received angel round investment.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 3, 2023 | Angel | — | 1 | — | — | Detail |
Feb 21, 2022 | Seed | — | 1 | Vinno Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Vinno Capital | — | Angel |